The Financial Impact of
Prior Authorization

Prior authorization is often discussed as a compliance or administrative step.

In reality, it’s a financial driver — one that directly impacts:

• operational cost
• denial rates
• revenue recovery
• cash flow timing

For many healthcare organizations, these costs are not fully visible until they scale.

This breakdown shows how prior authorization affects the revenue cycle — using recent industry data from CAQH, AMA, MGMA, and Change Healthcare.

Cost Structure of Prior Authorization

Managing prior authorization manually is significantly more expensive than automation.

• Manual prior authorization: ~$11 per transaction
• Automated workflows: ~$1–$2

Physician time: ~13 hours/week per physician

Denials add another layer:

• Initial denial rate: 10–15%
• Rework cost: $25–$40 per claim
• Complex cases: $100+

Claims not resubmitted: ~65%

Even before revenue is impacted, administrative overhead is already substantial.

How Denials Turn Into Financial Loss

The denial process follows a predictable pattern:

Claim submitted → Authorization issue → Denial

From there, two paths emerge:

• Rework → additional operational cost
• No resubmission → direct revenue loss

The second path is where the biggest financial impact occurs.

Denial Volume → Cost Conversion

Let’s translate this into real numbers.

Example:

• 7,000 claims per month
• 12% denial rate → 840 denials

Rework cost:

• 840 × $25–$40 = $21,000–$33,600 per month

Annualized: $250,000–$400,000+

And this only reflects rework — not lost revenue.

Resubmission Gap

Out of 100 denied claims:

• ~35 are resubmitted
• ~65 are never resubmitted

This creates a structural revenue gap — not because care wasn’t delivered, but because processes break.

Common Denial Drivers in Prior Authorization

Most denials are not random. They fall into repeatable categories:

• Missing authorization — not obtained in time
• Authorization mismatch — CPT/service misalignment
• Documentation gaps — clinical criteria not met
• Timing issues — expired or late submission
• Coverage decisions — not eligible

These are process issues, not clinical ones.

Cost Layers Across the Workflow

• Administrative processing → direct cost
• Denials → revenue disruption
• Rework → additional cost
• Non-resubmitted claims → revenue loss
• Delayed approvals → cash flow impact

This is why prior authorization is not just a task — it’s a system.

2026: Where the Industry Is Going

• Defined response timelines
• API-based data exchange (FHIR)
• Increased transparency in workflows

This signals a shift from manual processes to structured, data-driven authorization systems.

Prior authorization isn’t just slowing things down.

It’s quietly shaping the financial performance of healthcare organizations.

The real opportunity is not just speeding it up — but making it predictable, structured, and measurable.

---